5 assets in Muscular Atrophy

Therapeutic assets addressing Muscular Atrophy, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Aoc 1044 Muscular Atrophy	Avidity Biosciences, Inc.	P3	B (60)
Deramiocel Muscular Atrophy	Capricor Inc.	P3	B (60)
bio101 Muscular Atrophy	Biophytis	P2	CCC (53)
Semaglutide Muscular Atrophy	Biophytis	P2	CCC (53)
Apitegromab Muscular Atrophy	Scholar Rock, Inc.	P3	NR ()